Published in Med Pediatr Oncol on January 01, 1990
The proteus syndrome. Partial gigantism of the hands and/or feet, nevi, hemihypertrophy, subcutaneous tumors, macrocephaly or other skull anomalies and possible accelerated growth and visceral affections. Eur J Pediatr (1983) 3.70
Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature (1995) 2.93
Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum (1991) 2.91
Pars interarticularis fenestration in the treatment of foraminal lumbar disc herniation: a further surgical approach. Neurosurgery (1998) 2.68
Autoantibodies in Down's syndrome. Lancet (1966) 1.58
Cryptic telomeric rearrangements in subjects with mental retardation associated with dysmorphism and congenital malformations. J Med Genet (2001) 1.46
Bone mineralization and body composition in young patients with celiac disease. Am J Gastroenterol (1997) 1.46
Antiphospholipid antibodies in paediatrics. Eur J Pediatr (1994) 1.46
Spontaneous NBT reduction by monocytes as a marker of disease activity in children with histiocytosis. Br J Haematol (1990) 1.45
European experience of bone-marrow transplantation for severe combined immunodeficiency. Lancet (1990) 1.44
Late diagnosis in severe and mild intellectual disability in adulthood. J Intellect Disabil Res (2004) 1.43
Bone marrow transplantation for autosomal recessive osteopetrosis. A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation Group. J Pediatr (1994) 1.42
From a historical outline of transplants to the concept of biological ego. Pediatr Hematol Oncol (1992) 1.42
Human serum albumin: twenty-three genetic variants and their population distribution. Ann Hum Genet (1973) 1.40
Programmed bone-marrow donor for a leukaemic sibling, 10 years on. Lancet (1997) 1.39
The reconstitution of cellular immunity after bone marrow transplantation in children. Haematologica (1992) 1.39
Sinus histiocytosis with massive lymphoadenopathy (Rosai-Dorfman disease). Clinico-pathological analysis of a paediatric case. Eur J Pediatr (1992) 1.38
Additional data on the population distribution of human serum albumin genes; three new variants. Ann Hum Genet (1973) 1.35
In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI). Lancet (1996) 1.35
Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report. Bone Marrow Transplant (2003) 1.34
Immunology of Down syndrome: a review. Am J Med Genet Suppl (1990) 1.30
Adherence to antiretroviral therapy and its determinants in children with human immunodeficiency virus infection: a multicentre, national study. Acta Paediatr (2003) 1.29
Immunity in Down's syndrome. Eur J Pediatr (1978) 1.26
Serum IgG subclass concentrations in healthy subjects at different age: age normal percentile charts. Eur J Pediatr (1989) 1.25
Derangements of immunoglobulin levels, phytohemagglutinin responsiveness and T and B cell markers in Down's syndrome at different ages. Eur J Immunol (1975) 1.24
Outbreak of extended-spectrum beta-lactamase producing Serratia marcescens in an intensive care unit. FEMS Immunol Med Microbiol (1994) 1.24
L-asparaginase and blastogenesis. Lancet (1969) 1.21
Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. J Nucl Med (2001) 1.19
Mongolism and thyroid autoimmunity. Lancet (1965) 1.15
Congenital Alopecia and nail dystrophy associated with severe functional T-cell immunodeficiency in two sibs. Am J Med Genet (1996) 1.15
Long term survival after heart transplantation for doxorubicin induced cardiomyopathy. Arch Dis Child (1991) 1.13
Pseudodiastrophic dysplasia: a distinct newborn skeletal dysplasia. J Pediatr (1986) 1.10
Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission. AIDS (1995) 1.09
Malignancies in children with human immunodeficiency virus type 1 infection. The Italian Multicenter Study on Human Immunodeficiency Virus Infection in Children. Cancer (1991) 1.08
Ontogeny of secretory immunity: levels of secretory IgA and natural antibodies in saliva. Pediatr Res (1980) 1.08
Combined immunodeficiencies due to defects in signal transduction: defects of the gammac-JAK3 signaling pathway as a model. Immunobiology (2000) 1.06
Mutations in genetic variants of human serum albumin found in Italy. Proc Natl Acad Sci U S A (1990) 1.05
HIV-1 transmission through breast-milk: appraisal of risk according to duration of feeding. AIDS (1992) 1.04
Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors. Leukemia (2002) 1.03
Oral complications of pediatric hematopoietic cell transplantation: diagnosis and management. Support Care Cancer (2000) 1.01
Encephalocraniocutaneous lipomatosis and Proteus syndrome. Am J Med Genet (1986) 1.00
Puberty in perinatal HIV-1 infection: a multicentre longitudinal study of 212 children. AIDS (2001) 1.00
Immunodeficiency in Down's syndrome: T-lymphocyte subset imbalance in trisomic children. Clin Exp Immunol (1978) 1.00
Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, Leu 2a+ cells. Clin Exp Immunol (1984) 1.00
Immunological features of Down's syndrome: a review. J Intellect Disabil Res (1993) 0.98
Lymphocyte subpopulations in the neonate: identification of an immature subset of OKT8-positive, OKT3-negative cells. J Immunol (1983) 0.97
Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in Italy. AIEOP/FONOP-TMO Group. Italian Association of Paediatric Haemato-Oncology. Bone Marrow Transplant (1998) 0.96
The molecular defect in a COOH-terminal-modified and shortened mutant of human serum albumin. J Biol Chem (1989) 0.96
Stem cell transplantation for the Wiskott-Aldrich syndrome: a single-center experience confirms efficacy of matched unrelated donor transplantation. Bone Marrow Transplant (2006) 0.96
Partial response after intensive chemotherapy for adrenal cortical carcinoma in a child. Med Pediatr Oncol (1992) 0.95
Selective IgA deficiency: clinical and immunological evaluation of 50 pediatric patients. Eur J Pediatr (1980) 0.95
IgG subclass deficiency in patients with Down's syndrome and aberrant hepatitis B vaccine response. Scand J Immunol (1988) 0.95
Mortality from second tumour among long-term survivors of retinoblastoma: a retrospective analysis of the Italian retinoblastoma registry. Oncogene (2006) 0.93
Down syndrome: a model of immunodeficiency. Birth Defects Orig Artic Ser (1983) 0.93
Natural cytotoxicity impairment in familial haemophagocytic lymphohistiocytosis. Arch Dis Child (1988) 0.92
Down syndrome, autoimmunity and T regulatory cells. Clin Exp Immunol (2012) 0.92
Subcutaneous infusion of gammaglobulins in management of agammaglobulinaemia. Lancet (1982) 0.91
[Clinical evaluation of letosteine activity in the treatment of acute febrile bronchitis in children. Double-blind controlled study versus placebo]. Minerva Pediatr (1989) 0.90
Disorders of candidacidal activity and other neutrophil functions in three cases of chronic candidiasis. Helv Paediatr Acta (1979) 0.89
Clinical heterogeneity and reversibility of selective immunoglobulin A deficiency in 80 children. Lancet (1986) 0.88
No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients. Ann Oncol (2011) 0.88
B cell function after haploidentical in utero bone marrow transplantation in a patient with severe combined immunodeficiency. Bone Marrow Transplant (2002) 0.88
Prevalence of primary adult lactose malabsorption and awareness of milk intolerance in Italy. Am J Clin Nutr (1984) 0.88
Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial. Eur J Cancer (1996) 0.86
Comparative effects of thiamphenicol and chloramphenicol on haemopoiesis and lymphocyte transformation in vitro in man. Postgrad Med J (1974) 0.86
Genetic variants of human serum albumin in Italy: point mutants and a carboxyl-terminal variant. Proc Natl Acad Sci U S A (1994) 0.86
The impact of paediatric bone marrow transplantation on quality of life. Qual Life Res (1995) 0.85
Immune reconstitution after in utero bone marrow transplantation in a fetus with severe combined immunodeficiency with natural killer cells. Transplant Proc (1999) 0.85
Cytology of skin reactions to different inoculated substances (tuberculin, streptokinase, lipopolysaccharide of S. typhi, phytohaemagglutinin and pokeweed mitogen). Pathol Eur (1969) 0.85
Hematopoietic stem cell transplantation in Omenn syndrome: a single-center experience. Bone Marrow Transplant (2005) 0.85
T-lymphocyte deficiency in Down syndrome. Lancet (1977) 0.84
Evaluating daily nursing use and needs in the intensive care unit: a method to assess the rate and appropriateness of ICU resource use. Health Policy (2004) 0.84
Subcutaneous infusion of gamma globulins in the management of agammaglobulinemic patients. Birth Defects Orig Artic Ser (1983) 0.84
Further and new details on the Proteus syndrome. Eur J Pediatr (1984) 0.84
Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease. Int J Cardiol (2003) 0.84
Expression of protein kinase C beta1 confers resistance to TNFalpha- and paclitaxel-induced apoptosis in HT-29 colon carcinoma cells. Int J Cancer (2001) 0.84
Recurrent infections in children with "selective" IgA deficiency: association with IgG2 and IgG4 deficiency. Birth Defects Orig Artic Ser (1983) 0.83
Transformation by oncogenic ras-p21 alters the processing and subcellular localization of the lysosomal protease cathepsin D. J Cell Biochem (1999) 0.83
Daily classification of the level of care. A method to describe clinical course of illness, use of resources and quality of intensive care assistance. Intensive Care Med (2001) 0.83
[Guidelines for the diagnosis of childhood obstructive sleep apnea syndrome]. Minerva Pediatr (2004) 0.83
Phenotypic variability, neurological outcome and genetics background of 6-pyruvoyl-tetrahydropterin synthase deficiency. Clin Genet (2009) 0.83
Engrafted maternal T cells in human severe combined immunodeficiency: evidence for a TH2 phenotype and a potential role of apoptosis on the restriction of T-cell receptor variable beta repertoire. J Allergy Clin Immunol (1998) 0.83